Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis

Background: Growing evidence supports that cannabinoids relieve MS-related spasticity but little is known about cannabis use among people with MS (PwMS) and spasticity. Objective: To characterize cannabis use among PwMS and spasticity. Methods: As part of baseline data collection for a spasticity intervention trial in Oregon, PwMS and self-reported spasticity answered questions about cannabis use. Results: 54% reported ever using cannabis and 36% currently use. 79% use multiple routes of administration, 58% use at least daily. 79% find cannabis helpful for spasticity and 26% use cannabis and prescribed oral antispasticity medications. Conclusions: Many PwMS and spasticity use cannabis and report it helps their spasticity.